Indeterminate biliary strictures represent a diagnostic challenge requiring further work-up, which encompasses a variety of diagnostic modalities. We report a very rare case of B-cell acute lymphocytic leukemia presenting as a biliary stricture following remission of acute myeloid leukemia, which was initially treated with allogenic stem cell transplant. After multiple diagnostic modalities were implemented with no success, the use of cholangioscopy-guided biopsies was the key for the final diagnosis.
Symptomatic bile duct strictures can result in cholestasis, which presents with jaundice, icterus, pruritus, right upper quadrant pain, and steatorrhea. Generally, biliary strictures are classified into benign, indeterminate, and malignant strictures. The majority of biliary strictures are benign, and their most common etiology include iatrogenic injuries mostly from surgical procedures, autoimmune diseases, including primary sclerosing cholangitis, and liver transplantation.1 Malignant strictures derive most commonly from desmoplastic reaction in the setting of a hepatopancreaticobiliary malignancy. The most challenging biliary strictures are the indeterminate strictures, which are defined as biliary strictures with unknown etiology following cross-sectional imaging and tissue sampling. In these circumstances, significant attention needs to be drawn to the patient’s history, as the nature of an obstruction is often immediately clear at the time of investigation.2
The repertoire of noninvasive and invasive studies to diagnose indeterminate strictures is broad, with varying sensitivity and specificity. Magnetic resonance imaging and magnetic resonance cholangiopancreatography are safe to diagnose whether the stricture has benign or malignant features but are hampered by the fact that tissue sampling cannot be performed. On the other hand, endoscopic retrograde cholangiopancreatography (ERCP) is an invasive procedure that allows tissue sampling to which many authors refer as the gold standard test for biliary strictures.3,4 Diagnostic modalities include biliary brushing (sensitivity 57%, specificity 90%–100%), fluoroscopic-guided biopsies (sensitivity 74%, specificity 70%), fluorescence in situ hybridization (sensitivity 34%, specificity 91%), cholangioscopy with directed biopsies (sensitivity 43%–81%, specificity 90%–100%), endoscopic ultrasound with fine-needle aspiration (sensitivity 43%–89%, specificity 100%), intraductal ultrasound (sensitivity 83%–91%, specificity 50%–92%), and confocal laser endomicroscopy (sensitivity 98%, specificity 67%).4,5 Combination of modalities may increase the diagnostic yield.
A 65-year-old man presented with 1 week of fever, right upper quadrant pain, jaundice, pruritus, and subjective steatorrhea. He had a medical history of acute myeloid leukemia arising from myelodysplastic syndrome that was treated with allogenic stem cell transplant at an outside institution. The patient had been in remission for 4 years. The transplant was complicated by graft versus host disease, hemosiderosis, and chronic mild thrombocytopenia.
Initial work-up revealed a hyperbilirubinemia of 20.1 mg/dL, with direct and indirect bilirubin 14.2 and 5.9 mg/dL, respectively, alkaline phosphatase 319 U/L, alanine aminotransferase 96 U/L, aspartate aminotransferase 215 U/L, and a normal lipase. Magnetic resonance cholangiopancreatography (Figure 1) showed a narrow segment in the proximal common hepatic duct approximately 1–2 cm distal to the confluence. A subsequent ERCP confirmed the stricture. Brush biopsies remained nondiagnostic, and cholestasis was treated with placement of a biliary plastic stent. After ERCP, both symptoms and laboratory values improved, and the patient was discharged with a diagnosis of an indeterminate biliary stricture and acute cholangitis.
Figure 1. Magnetic resonance cholangiopancreatography showing narrowing of the common hepatic duct 1-2 cm distal to the confluence, with the narrowing approximately 2 cm long, and also noted minor proximal biliary ductal dilatation.
The patient presented 10 days later to our institution for further diagnostic management of the biliary stricture. At that point, he denied fever, chills, or any other gastrointestinal symptoms. Vital signs were within normal limits. On physical exam, the patient was in no acute distress, with soft abdomen that was nondistended and nontender. Mild jaundice and mild scleral icterus were present. Laboratory work-up revealed a total bilirubin to 2.1 mg/dL, with direct bilirubin of 1.2 mg/dL and normal liver transaminases. Carbohydrate antigen 19-9 and carcinoembryonic antigen were within normal limits as well. A repeat ERCP confirmed a common hepatic duct stricture of 2 cm with upstream bilateral intrahepatic ductal dilation (Figure 2).
Figure 2. Endoscopic retrograde cholangiopancreatography showed common hepatic duct stricture of 2 cm with upstream bilateral intrahepatic ductal dilation.
The biliary tree was swept with an 8.5-mm balloon. Resistance was met upon passing the inflated balloon through the stricture. Subsequent cholangioscopy (SpyGlass, Boston Scientific, MA) visualized nodularity and friability in the area of the stricture. Biliary brushing and fluorescence in situ hybridization remained nondiagnostic; however, a targeted biopsy with the Howell biliary introducer forceps (Cook Medical, NC) demonstrated infiltrating atypical mononucleated cells (Figure 3).
Figure 3. Hematoxylin and eosin stain showing infiltrating atypical mononucleated cells at (A) 4x magnification and (B) 20x magnification.
Subsequent open biopsy of peritoneal nodules, cytology study of the peritoneal fluid, and bone marrow biopsy were performed. The flow cytometry analysis identified the blasts with mixed phenotype of both lymphoblasts and myeloblasts. With additional immunohistochemical studies, the blasts were positive for CD79a, terminal deoxynucleotidyl transferase, CD34, and CD10 and negative for myeloperoxidase (Figure 4). The profile confirmed the B-cell lineage of the blasts and a diagnosis of B-cell lymphoblastic leukemia was made.
Figure 4. Immunohistochemical studies testing positive for (A) CD79a, (B) TdT, (C) CD34, and (D) negative for myeloperoxidase.
B-cell lymphocytic leukemia is a hematologic cancer that originates in the bone marrow and can metastasize to other organs. Previous case reports of lymphocytic leukemia have presented with cholestasis symptoms, but both were intrahepatic and diagnosed by liver biopsy.6,7 A study of 6610 patients in MD Anderson Cancer Center to define the role of ERCP after hematopoietic stem cell transplant in patients presenting with jaundice, found that out of 40 patients that underwent ERCP, 17 had biliary strictures. From those 17, 76% (n = 13) were malignant.8 Of note, malignant strictures presenting as recurrence of a primary hematologic malignancy occurred more frequently after autologous stem cell transplant than after an allogenic stem cell transplant.8 Interestingly, this study did not demonstrate graft versus host disease as etiology for biliary strictures.
This case delineates the advantages of targeted biopsy with the use of the latest innovation in the field, high-resolution cholangioscopy in the work-up of indeterminate biliary strictures. This technique allows for detailed inspection of the biliary tree and facilitates targeted biopsies on lesions with malignant characteristics, such as irregular or tortuous vessels.9 The increased diagnostic yield of high-resolution cholangioscopy is, however, hampered by its high costs and complication rate of 0.3%, including pancreatitis and cholangitis.10
Author contributions: All authors contributed equally to the manuscript. J. Melendez-Rosado is the article guarantor.
Financial disclosure: None to report.
Informed consent was obtained for this case report.
Acknowledgements: We would like to acknowledge our research department for help preparing this manuscript.
Correspondence: Jose Melendez-Rosado, Division of Internal Medicine, Mayo Clinic, 4500 San Pablo Rd, Jacksonville, FL 32224 (email@example.com).
Received October 20, 2015; Accepted Feburary 10, 2016
- Costamagna G, Boškoski I. Current treatment of benign biliary strictures. Ann Gastroenterol. 2013;26(1):37–40. PubMed
- Petersen BT. Indeterminate biliary stricture. In: Baron TH, Kozarek RA, Carr-Locke DL, eds. ERCP. 2nd ed.
Philadelphia, PA: Elsevier, Inc; 2013:365–77.
- Adler DG, Baron TH, Davila RE, et al. ASGE guideline: The role of ERCP in diseases of the biliary tract and the pancreas. Gastrointest Endosc. 2005;62(1):1–8. Article | PubMed
- Yoon WJ, Brugge WR. Endoscopic evaluation of bile duct strictures. Gastrointest Endosc Clin N Am. 2013;23(2):277–93. Article | PubMed
- Kipp BR, Stadheim LM, Halling SA, et al. A comparison of routine cytology and fluorescence in situ hybridizatio
n for the detection of malignant bile duct strictures. Am J Gastroenterol. 2004;99(9)16751–81. Article | PubMed
- Patel KJ, Latif SU, de Calaca WM. An unusual presentation of precursor T cell lymphoblastic leukemia/lymphoma with cholestatic jaundice: Case report. J Hematol Oncol. 2009;2:12. Article | PubMed
- Siddique MN, Popalzai M, Aoun N, et al. Precursor B-cell acute lymphoblastic leukemia presenting as obstructive jaundice: A case report. J Med Case Rep. 2011;5:269. Article | PubMed
- Kim HN, Alousi AM, Lee JH, et al. Role of ERCP in patients after hematopoietic stem cell transplantation. Gastrointest Endosc. 2011;74(4):817–24. Article | PubMed
- Kim HJ, Kim MH, Lee SK, et al. Tumor vessel: A valuable cholangioscopic clue of malignant biliary stricture. Gastrointest Endosc. 2000;52(5):635–8. Article | PubMed
- Hoffman A, Rey JW, Kiesslich R. Single operator choledochoscopy and its role in daily endoscopy routine. World J Gastrointest Endosc. 2013;5(5):203–10. Article | PubMed
© 2016 Melendez-Rosado et al. This work is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License. To view a copy of this license, visit http://creativecommons.org/licenses/by-nc-nd/4.0.